These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35153156)

  • 1. Secnidazole for Trichomoniasis in Women and Men.
    Muzny CA; Van Gerwen OT
    Sex Med Rev; 2022 Apr; 10(2):255-262. PubMed ID: 35153156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secnidazole: a treatment for trichomoniasis in adolescents and adults.
    Muzny CA; Van Gerwen OT; Legendre D
    Expert Rev Anti Infect Ther; 2022 Aug; 20(8):1067-1076. PubMed ID: 35642509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of single-dose oral secnidazole for the treatment of trichomoniasis in women co-infected with trichomoniasis and bacterial vaginosis: a post hoc subgroup analysis of phase 3 clinical trial data.
    Muzny CA; Van Gerwen OT; Kaufman G; Chavoustie S
    BMJ Open; 2023 Aug; 13(8):e072071. PubMed ID: 37550019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Single Oral Dosing of Secnidazole for Trichomoniasis in Women: Results of a Phase 3, Randomized, Double-Blind, Placebo-Controlled, Delayed-Treatment Study.
    Muzny CA; Schwebke JR; Nyirjesy P; Kaufman G; Mena LA; Lazenby GB; Van Gerwen OT; Graves KJ; Arbuckle J; Carter BA; McMahon CP; Eder S; Shaw J; Pandey B; Chavoustie SE
    Clin Infect Dis; 2021 Sep; 73(6):e1282-e1289. PubMed ID: 33768237
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Mtshali A; Ngcapu S; Govender K; Sturm AW; Moodley P; Joubert BC
    Microbiol Spectr; 2022 Aug; 10(4):e0091222. PubMed ID: 35863010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis.
    Gillis JC; Wiseman LR
    Drugs; 1996 Apr; 51(4):621-38. PubMed ID: 8706597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secnidazole. A 5-nitroimidazole derivative with a long half-life.
    Videau D; Niel G; Siboulet A; Catalan F
    Br J Vener Dis; 1978 Apr; 54(2):77-80. PubMed ID: 305808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis.
    Schwebke JR; Morgan FG; Koltun W; Nyirjesy P
    Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
    van Schalkwyk J; Yudin MH;
    J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Ghosh AP; Aycock C; Schwebke JR
    Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29439963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity of amixicile against T. vaginalis from clinical isolates.
    Jain E; Zaenker EI; Hoffman PS; Warren CA
    Parasitol Res; 2022 Aug; 121(8):2453-2455. PubMed ID: 35676563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with secnidazole for trichomoniasis in the setting of metronidazole hypersensitivity.
    Kufel WD; Asiago-Reddy EA; Parsels KA; Sanyal S; Coyne JL
    Int J STD AIDS; 2021 Nov; 32(13):1271-1273. PubMed ID: 34392726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secnidazole: next-generation antimicrobial agent for bacterial vaginosis treatment.
    Nyirjesy P; Schwebke JR
    Future Microbiol; 2018 Apr; 13():507-524. PubMed ID: 29327947
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
    Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
    Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secnidazole Treatment of Bacterial Vaginosis: A Randomized Controlled Trial.
    Hillier SL; Nyirjesy P; Waldbaum AS; Schwebke JR; Morgan FG; Adetoro NA; Braun CJ
    Obstet Gynecol; 2017 Aug; 130(2):379-386. PubMed ID: 28697102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
    Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
    Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vitro Testing of Trichomonas vaginalis Drug Susceptibility: Evaluation of Minimal Lethal Concentrations for Metronidazole and Tinidazole That Correspond With Treatment Failure.
    Augostini P; Bradley ELP; Raphael BH; Secor WE
    Sex Transm Dis; 2023 Jun; 50(6):370-373. PubMed ID: 36849257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful Treatment of Persistent 5-Nitroimidazole-Resistant Trichomoniasis With an Extended Course of Oral Secnidazole Plus Intravaginal Boric Acid.
    McNeil CJ; Williamson JC; Muzny CA
    Sex Transm Dis; 2023 Apr; 50(4):243-246. PubMed ID: 36730040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic aspects of trichomoniasis].
    Vukićević J; Jankicević J
    Srp Arh Celok Lek; 2003; 131(3-4):156-61. PubMed ID: 14608880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent and recurrent Trichomonas vaginalis infections: epidemiology, treatment and management considerations.
    Seña AC; Bachmann LH; Hobbs MM
    Expert Rev Anti Infect Ther; 2014 Jun; 12(6):673-85. PubMed ID: 24555561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.